Apimeds Pharmaceuticals US (APUS) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Apimeds Pharmaceuticals US is the larger company by market cap ($8.3 million vs $5.6 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | SNOA |
|---|---|---|
| Share price | $5.51 | $1.16 |
| Market cap | $8.32M | $5.55M |
| 1-day change | -21.84% | -4.92% |
| YTD return | -66.40% | — |
| 1-year return | -70.53% | — |
| EPS (TTM) | $-36.03 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $4.30 |
| 52-week low | $1.51 | $0.85 |
| Distance from 52-week high | -90.77% | -73.02% |
| Average volume | 3.66M | 107.65K |
| Shares outstanding | 1.51M | 4.79M |
| Employees | — | 10 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Healthcare · Drug Manufacturers - Specialty & Generic
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 10 employees
APUS vs SNOA FAQ
Which is bigger, Apimeds Pharmaceuticals US or Sonoma Pharmaceuticals?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $8.32M compared with $5.55M for Sonoma Pharmaceuticals (SNOA).
Are Apimeds Pharmaceuticals US and Sonoma Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.